Avrobio | 销售和管理费用

Selling And Administration Expenses 更改 日
Adcock Ingram Holdings ZAR 989.77M 27M 2023-06
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Celltrion KRW 20.24B 102.51B 2024-03
Cspc Pharmaceutical CNY 2.44B 7.23M 2023-12
Dianthus Therapeutics USD 5.64M 1.01M 2024-03
Ecofibre AUD 9.89M 2.34M 2023-06
Gilead Sciences USD 1.38B 233M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Kangmei Pharma CNY 222.13M 22.97M 2024-03
Knight Therapeutics CAD 23.19M 4.26M 2024-03
Laboratorios Farma EUR 54.03M 3.27M 2023-06
MacroGenics USD 14.71M 2.15M 2024-03
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 22.92M 6.46M 2023-06
Neuren Pharmaceuticals AUD 3.69M 2.98M 2023-06
Organigram Holdings CAD 20.86M 3.52M 2024-03
Pfizer USD 3.5B 976M 2024-03
Pharma Mar EUR 10.96M 448K 2024-03
Probiotec AUD 15.11M 1.77M 2023-06
Qiagen NV USD 138.69M 7.26M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
Sanofi EUR 2.6B 26M 2024-03
Sarepta Therapeutics USD 127M 6.11M 2024-03
Sartorius EUR 223.9M 11.8M 2024-03
Sino Biopharmaceutical CNY 6.44B 814.26M 2023-06
Takeda JPY 267.52B 14.57B 2023-12
Tilray USD 61.1M 976K 2024-02
Zz Pientze Pharmaceu 227.97M 68.21M 2023-09



Avrobio 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.